Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Distance traveled for treatment of cervical cancer: who travels the farthest, and does it impact outcome?

Gunderson CC, Nugent EK, McMeekin DS, Moore KN.

Int J Gynecol Cancer. 2013 Jul;23(6):1099-103. doi: 10.1097/IGC.0b013e3182989464.

PMID:
23765207
2.

Primary uterine cancer in Maryland: impact of distance on access to surgical care at high-volume hospitals.

Gunderson CC, Tergas AI, Fleury AC, Diaz-Montes TP, Giuntoli RL 2nd.

Int J Gynecol Cancer. 2013 Sep;23(7):1244-51. doi: 10.1097/IGC.0b013e31829ea002.

PMID:
23899587
3.

Endometrial cancer surgery in Arizona: a statewide analysis of access to care.

Benjamin I, Dalton H, Qiu Y, Cayco L, Johnson WG, Balducci J.

Gynecol Oncol. 2011 Apr;121(1):83-6. doi: 10.1016/j.ygyno.2010.11.028. Epub 2011 Jan 5.

PMID:
21208650
4.

Association between travel distance and metastatic disease at diagnosis among patients with colon cancer.

Massarweh NN, Chiang YJ, Xing Y, Chang GJ, Haynes AB, You YN, Feig BW, Cormier JN.

J Clin Oncol. 2014 Mar 20;32(9):942-8. doi: 10.1200/JCO.2013.52.3845. Epub 2014 Feb 10.

5.

Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients.

Schroen AT, Brenin DR, Kelly MD, Knaus WA, Slingluff CL Jr.

J Clin Oncol. 2005 Oct 1;23(28):7074-80.

PMID:
16192590
6.

A randomized controlled study of single-agent cisplatin and radiotherapy versus docetaxel/cisplatin and radiotherapy in high-risk early-stage cervical cancer after radical surgery.

Pu J, Qin SS, Ding JX, Zhang Y, Zhu WG, Yu CH, Li T, Tao GZ, Ji FZ, Zhou XL, Han JH, Ji YL, Sun JX.

J Cancer Res Clin Oncol. 2013 Apr;139(4):703-8. doi: 10.1007/s00432-013-1373-9. Epub 2013 Jan 18.

PMID:
23328996
7.

Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.

Okazawa M, Mabuchi S, Isohashi F, Suzuki O, Yoshioka Y, Sasano T, Ohta Y, Kamiura S, Ogawa K, Kimura T.

Int J Gynecol Cancer. 2013 Mar;23(3):567-75. doi: 10.1097/IGC.0b013e31828703fd.

PMID:
23385284
8.

Disparities in survival among women with invasive cervical cancer: a problem of access to care.

Brookfield KF, Cheung MC, Lucci J, Fleming LE, Koniaris LG.

Cancer. 2009 Jan 1;115(1):166-78. doi: 10.1002/cncr.24007.

9.

Prognostic factors and survival in patients with metastatic or recurrent carcinoma of the uterine cervix.

Eralp Y, Saip P, Sakar B, Kucucuk S, Aydiner A, Dincer M, Aslay I, Topuz E.

Int J Gynecol Cancer. 2003 Jul-Aug;13(4):497-504.

PMID:
12911727
10.

Chemoradiation for invasive cervical cancer in elderly patients: outcomes and morbidity.

Goodheart M, Jacobson G, Smith BJ, Zhou L.

Int J Gynecol Cancer. 2008 Jan-Feb;18(1):95-103. Epub 2007 Apr 26.

PMID:
17466049
11.

The impact of race and partner status on patterns of care and survival in young women with early-stage cervical cancer.

Grover S, Showalter S, Kraft KH, Suneja G, Lin L.

Int J Gynecol Cancer. 2013 Mar;23(3):494-9. doi: 10.1097/IGC.0b013e318280824d.

PMID:
23388613
12.

A retrospective review of patients with stage IB2 cervical cancer treated with radical radiation versus radical surgery as a primary modality.

Alleyne-Mike K, van Wijk L, Hunter A.

Int J Gynecol Cancer. 2013 Sep;23(7):1287-94. doi: 10.1097/IGC.0b013e31829fb834.

PMID:
23863456
13.

The impact of pre-therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer.

Odunsi KO, Lele S, Ghamande S, Seago P, Driscoll DL.

Eur J Gynaecol Oncol. 2001;22(5):325-30.

PMID:
11766731
14.

Radical surgery with individualized postoperative radiation for stage IB cervical cancer: oncologic outcomes and severe complications.

Sandadi S, Tanner EJ, Khoury-Collado F, Kostolias A, Makker V, Chi DS, Sonoda Y, Alektiar KM, Barakat RR, Abu-Rustum NR.

Int J Gynecol Cancer. 2013 Mar;23(3):553-8. doi: 10.1097/IGC.0b013e3182849d53.

PMID:
23392402
15.

Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.

Werner-Wasik M, Schmid CH, Bornstein L, Ball HG, Smith DM, Madoc-Jones H.

Int J Radiat Oncol Biol Phys. 1995 Jul 30;32(5):1309-17.

PMID:
7635770
16.

Racial disparities in patients with head and neck squamous cell carcinoma.

Gourin CG, Podolsky RH.

Laryngoscope. 2006 Jul;116(7):1093-106. Erratum in: Laryngoscope. 2006 Nov;116(11):2098.

PMID:
16826042
17.

Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival.

Kasuya G, Ogawa K, Iraha S, Nagai Y, Hirakawa M, Toita T, Kakinohana Y, Kudaka W, Inamine M, Ariga T, Aoki Y, Murayama S.

Anticancer Res. 2013 May;33(5):2199-204.

PMID:
23645776
18.

Does histology influence prognosis in patients with early-stage cervical carcinoma?

Grisaru D, Covens A, Chapman B, Shaw P, Colgan T, Murphy J, DePetrillo D, Lickrish G, Laframboise S, Rosen B.

Cancer. 2001 Dec 15;92(12):2999-3004.

PMID:
11753977
19.

Cervical cancer survival for patients referred to a tertiary care center in Kentucky.

Seamon LG, Tarrant RL, Fleming ST, Vanderpool RC, Pachtman S, Podzielinski I, Branscum AJ, Feddock JM, Randall ME, Desimone CP.

Gynecol Oncol. 2011 Dec;123(3):565-70. doi: 10.1016/j.ygyno.2011.09.008. Epub 2011 Oct 2.

PMID:
21963092
20.

Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix?

Shingleton HM, Bell MC, Fremgen A, Chmiel JS, Russell AH, Jones WB, Winchester DP, Clive RE.

Cancer. 1995 Nov 15;76(10 Suppl):1948-55.

Supplemental Content

Support Center